{"transactions":[{"id":918933,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":67695,"kind":"person","name":"Bohen Sean","position":1,"cik":"0001831218","reported_name":"Bohen Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Performance Stock Options (Right to Buy)","published_at":"2026-02-05T02:30:04.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":275000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The performance-based stock options will be eligible to vest during two distinct performance periods, each beginning on February 2, 2026 and ending on December 31, 2029 and December 31, 2030, respectively, based on the Issuer's stock price trading at certain pre-determined price thresholds as measured by the average closing price per share of the Issuer's stock over a consecutive thirty (30) day trading period during each such performance period. Once a price threshold is achieved, the portion of the award related to such threshold will vest upon the date set forth in the certification by the Compensation Committee certifying that such price threshold was achieved, subject to the Reporting Person's continuous service as of the applicable certification date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Notwithstanding the foregoing, if the Reporting Person's continuous service is terminated without Cause (as defined in the Reporting Person's offer letter), the performance-based stock options shall remain outstanding and eligible to vest for twelve (12) months following such termination."}],"balance_after":275000,"derivative":{"exercise_price":25.65,"expiration_date":"2036-02-01","underlying":"Common Stock","underlying_shares":275000},"source":{"system":"sec-edgar","filing":"0001831218-26-000002","document":"form4-02042026_090201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1750284/000183121826000002/form4-02042026_090201.xml","form_type":"4"}},{"id":918932,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":67695,"kind":"person","name":"Bohen Sean","position":1,"cik":"0001831218","reported_name":"Bohen Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-05T02:30:04.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":850000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vest on February 2, 2027, and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date."}],"balance_after":850000,"derivative":{"exercise_price":25.65,"expiration_date":"2036-02-01","underlying":"Common Stock","underlying_shares":850000},"source":{"system":"sec-edgar","filing":"0001831218-26-000002","document":"form4-02042026_090201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1750284/000183121826000002/form4-02042026_090201.xml","form_type":"4"}},{"id":956970,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":67695,"kind":"person","name":"Bohen Sean","position":1,"cik":"0001831218","reported_name":"Bohen Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-12-30T21:05:14.000Z","date":"2025-12-26","kind":"gift","planned":false,"acquired":false,"shares":8500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the gift of common stock to a charitable donor advised fund."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 4,488 shares acquired under the Issuer's Employee Stock Purchase Plan on June 30, 2025."}],"balance_after":237650,"source":{"system":"sec-edgar","filing":"0001831218-25-000004","document":"form4-12302025_091209.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1750284/000183121825000004/form4-12302025_091209.xml","form_type":"4"}},{"id":1235075,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":67695,"kind":"person","name":"Bohen Sean","position":1,"cik":"0001831218","reported_name":"Bohen Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-03T21:15:14.000Z","date":"2025-02-28","kind":"grant","planned":false,"acquired":true,"shares":650000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vest on February 28, 2026 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date."}],"balance_after":650000,"derivative":{"exercise_price":4.37,"expiration_date":"2035-02-27","underlying":"Common Stock","underlying_shares":650000},"source":{"system":"sec-edgar","filing":"0001415889-25-006147","document":"form4-03032025_090310.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1750284/000141588925006147/form4-03032025_090310.xml","form_type":"4"}},{"id":1335016,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":67695,"kind":"person","name":"Bohen Sean","position":1,"cik":"0001831218","reported_name":"Bohen Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-12-12T00:52:49.000Z","date":"2024-12-11","kind":"sale","planned":false,"acquired":false,"shares":1267,"price":9.39,"value":11897.13,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of PRSUs. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The weighted average sale price for the transaction reported was $9.39, and the range of prices was between $9.31 and $9.74. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":241662,"source":{"system":"sec-edgar","filing":"0001415889-24-029024","document":"form4-12122024_121245.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1750284/000141588924029024/form4-12122024_121245.xml","form_type":"4"}},{"id":1335015,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":67695,"kind":"person","name":"Bohen Sean","position":1,"cik":"0001831218","reported_name":"Bohen Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-12-12T00:52:49.000Z","date":"2024-12-11","kind":"sale","planned":false,"acquired":false,"shares":55907,"price":8.66,"value":484154.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of PRSUs. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The weighted average sale price for the transaction reported was $8.66, and the range of prices was between $8.22 and $9.21. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":242929,"source":{"system":"sec-edgar","filing":"0001415889-24-029024","document":"form4-12122024_121245.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1750284/000141588924029024/form4-12122024_121245.xml","form_type":"4"}},{"id":1335014,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":67695,"kind":"person","name":"Bohen Sean","position":1,"cik":"0001831218","reported_name":"Bohen Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-12-12T00:52:49.000Z","date":"2024-12-10","kind":"sale","planned":false,"acquired":false,"shares":52328,"price":9.37,"value":490313.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of PRSUs. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The weighted average sale price for the transaction reported was $9.37, and the range of prices was between $8.87 and $9.70. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":298836,"source":{"system":"sec-edgar","filing":"0001415889-24-029024","document":"form4-12122024_121245.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1750284/000141588924029024/form4-12122024_121245.xml","form_type":"4"}},{"id":1335013,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":67695,"kind":"person","name":"Bohen Sean","position":1,"cik":"0001831218","reported_name":"Bohen Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-12-12T00:52:49.000Z","date":"2024-12-09","kind":"grant","planned":false,"acquired":true,"shares":204750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On November 11, 2022, the Reporting Person was granted certain performance restricted stock units (\"PRSUs\") for 315,000 shares, which were subject to vesting upon certification by the Compensation Committee of the Company's achievement of two different performance milestones. 35% of the award previously vested on November 20, 2023. On December 9, 2024, the Compensation Committee certified that the remaining 65% of the award vested based on achievement of certain performance criteria."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,489 shares acquired under the Issuer's Employee Stock Purchase Plan on June 30, 2024."}],"balance_after":351164,"source":{"system":"sec-edgar","filing":"0001415889-24-029024","document":"form4-12122024_121245.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1750284/000141588924029024/form4-12122024_121245.xml","form_type":"4"}},{"id":1658077,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":67695,"kind":"person","name":"Bohen Sean","position":1,"cik":"0001831218","reported_name":"Bohen Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-05T22:30:19.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":621500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vest on February 1, 2025 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date."}],"balance_after":621500,"derivative":{"exercise_price":15.25,"expiration_date":"2034-01-31","underlying":"Common Stock","underlying_shares":621500},"source":{"system":"sec-edgar","filing":"0001415889-24-002607","document":"form4-02052024_050202.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1750284/000141588924002607/form4-02052024_050202.xml","form_type":"4"}},{"id":1730700,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":67695,"kind":"person","name":"Bohen Sean","position":1,"cik":"0001831218","reported_name":"Bohen Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2023-11-23T00:00:19.000Z","date":"2023-11-22","kind":"sale","planned":false,"acquired":false,"shares":27932,"price":13.9,"value":388254.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of PRSUs. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a\ndiscretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The weighted average sale price for the transaction reported was $13.90, and the range of prices was between $13.62 and $14.16. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":144925,"source":{"system":"sec-edgar","filing":"0001415889-23-015456","document":"form4-11222023_071103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1750284/000141588923015456/form4-11222023_071103.xml","form_type":"4"}},{"id":1730699,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":67695,"kind":"person","name":"Bohen Sean","position":1,"cik":"0001831218","reported_name":"Bohen Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2023-11-23T00:00:19.000Z","date":"2023-11-21","kind":"sale","planned":false,"acquired":false,"shares":2602,"price":15.29,"value":39784.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of PRSUs. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a\ndiscretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The weighted average sale price for the transaction reported was $15.29, and the range of prices was between $15.20 and $15.95. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":172857,"source":{"system":"sec-edgar","filing":"0001415889-23-015456","document":"form4-11222023_071103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1750284/000141588923015456/form4-11222023_071103.xml","form_type":"4"}},{"id":1730698,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":67695,"kind":"person","name":"Bohen Sean","position":1,"cik":"0001831218","reported_name":"Bohen Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2023-11-23T00:00:19.000Z","date":"2023-11-21","kind":"sale","planned":false,"acquired":false,"shares":26691,"price":14.84,"value":396094.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of PRSUs. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a\ndiscretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The weighted average sale price for the transaction reported was $14.84, and the range of prices was between $14.20 and $15.19. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":175459,"source":{"system":"sec-edgar","filing":"0001415889-23-015456","document":"form4-11222023_071103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1750284/000141588923015456/form4-11222023_071103.xml","form_type":"4"}},{"id":1730697,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":67695,"kind":"person","name":"Bohen Sean","position":1,"cik":"0001831218","reported_name":"Bohen Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2023-11-23T00:00:19.000Z","date":"2023-11-20","kind":"grant","planned":false,"acquired":true,"shares":110250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On November 11, 2022, the Reporting Person was granted certain performance restricted stock units (\"PRSUs\") for 315,000 shares, which are subject to vesting\nupon certification by the Compensation Committee of the Company's achieving two different performance milestones. The Compensation Committee certified on\nNovember 20, 2023 that 35% of the award vested based upon the certification by the Compensation Committee as to certain performance criteria."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 5,000 shares acquired under the issuer's Employee Stock Purchase Plan on November 15, 2022 and 12,621 shares acquired under the issuer's Employee Stock Purchase Plan on May 15, 2023."}],"balance_after":202150,"source":{"system":"sec-edgar","filing":"0001415889-23-015456","document":"form4-11222023_071103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1750284/000141588923015456/form4-11222023_071103.xml","form_type":"4"}},{"id":2034999,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":67695,"kind":"person","name":"Bohen Sean","position":1,"cik":"0001831218","reported_name":"Bohen Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-02T22:29:39.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":550000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vest on February 1, 2024 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date."}],"balance_after":550000,"derivative":{"exercise_price":4.87,"expiration_date":"2033-01-31","underlying":"Common Stock","underlying_shares":550000},"source":{"system":"sec-edgar","filing":"0001209191-23-006284","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1750284/000120919123006284/doc4.xml","form_type":"4"}},{"id":2151706,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":67695,"kind":"person","name":"Bohen Sean","position":1,"cik":"0001831218","reported_name":"Bohen Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2022-09-23T21:35:48.000Z","date":"2022-09-21","kind":"purchase","acquired":true,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This amendment is being filed solely to correct the transaction code in column 3 of Table I from code \"A\" to code \"P\"."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average purchase price for the transaction reported was $3.16, and the range of prices were between $3.15 and $3.19. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price will be provided."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 5 shares acquired under the issuer's Employee Stock Purchase Plan."}],"balance_after":74279,"source":{"system":"sec-edgar","filing":"0001415889-22-009915","document":"form4a-09232022_020934.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1750284/000141588922009915/form4a-09232022_020934.xml","form_type":"4/A","original_submission_date":"2022-09-22"}},{"id":2152511,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":67695,"kind":"person","name":"Bohen Sean","position":1,"cik":"0001831218","reported_name":"Bohen Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2022-09-22T22:51:08.000Z","date":"2022-09-21","kind":"grant","acquired":true,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average purchase price for the transaction reported was $3.16, and the range of prices were between $3.15 and $3.19. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price will be provided."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 5 shares acquired under the issuer's Employee Stock Purchase Plan."}],"balance_after":74279,"source":{"system":"sec-edgar","filing":"0001415889-22-009880","document":"form4-09222022_030957.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1750284/000141588922009880/form4-09222022_030957.xml","form_type":"4"}},{"id":2412772,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":67695,"kind":"person","name":"Bohen Sean","position":1,"cik":"0001831218","reported_name":"Bohen Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-04T00:02:13.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":812250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vest on February 1, 2023 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date."}],"balance_after":812250,"derivative":{"exercise_price":7.02,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":812250},"source":{"system":"sec-edgar","filing":"0001415889-22-001055","document":"form4-02032022_040258.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1750284/000141588922001055/form4-02032022_040258.xml","form_type":"4"}},{"id":2541271,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":67695,"kind":"person","name":"Bohen Sean","position":1,"cik":"0001831218","reported_name":"Bohen Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-15T22:44:40.000Z","date":"2021-10-14","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"(A) 256,992 of the shares subject to the option vest on September 1, 2021, (B) 2,411 of the shares subject to the option vest on January 1, 2022 and 2,410 of the shares subject to the option vest on January 1 of each of 2023 and 2024 and (C) 23,143 of the shares subject to the option vest on the 1st day of each month (other than on September 1, 2021 and each of January 1, 2022, 2023 and 2024) following September 1, 2021, plus an additional 23 shares on September 1, 2024. Subject to, in each case of (A) - (C) above, the Reporting Person's continuous service on each applicable vesting date. The stock option is early exercisable."}],"balance_after":966316,"derivative":{"exercise_price":4.824,"expiration_date":"2030-11-18","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001415889-21-004885","document":"form4-10152021_031031.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1750284/000141588921004885/form4-10152021_031031.xml","form_type":"4"}},{"id":2541270,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":67695,"kind":"person","name":"Bohen Sean","position":1,"cik":"0001831218","reported_name":"Bohen Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2021-10-15T22:44:40.000Z","date":"2021-10-14","kind":"sale","acquired":false,"shares":351,"price":31.17,"value":10940.67,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The weighted average sale price for the transaction reported was $31.17, and the range of prices were between $31.00 and $31.28. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":52514,"source":{"system":"sec-edgar","filing":"0001415889-21-004885","document":"form4-10152021_031031.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1750284/000141588921004885/form4-10152021_031031.xml","form_type":"4"}},{"id":2541269,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":67695,"kind":"person","name":"Bohen Sean","position":1,"cik":"0001831218","reported_name":"Bohen Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2021-10-15T22:44:40.000Z","date":"2021-10-14","kind":"sale","acquired":false,"shares":4649,"price":30.42,"value":141422.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $30.42, and the range of prices were between $30.00 and $30.99. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":52865,"source":{"system":"sec-edgar","filing":"0001415889-21-004885","document":"form4-10152021_031031.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1750284/000141588921004885/form4-10152021_031031.xml","form_type":"4"}},{"id":2541268,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":67695,"kind":"person","name":"Bohen Sean","position":1,"cik":"0001831218","reported_name":"Bohen Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2021-10-15T22:44:40.000Z","date":"2021-10-14","kind":"exercise","acquired":true,"shares":5000,"price":4.824,"value":24120.0,"ownership":{"direct":true},"balance_after":57514,"source":{"system":"sec-edgar","filing":"0001415889-21-004885","document":"form4-10152021_031031.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1750284/000141588921004885/form4-10152021_031031.xml","form_type":"4"}},{"id":2556348,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":67695,"kind":"person","name":"Bohen Sean","position":1,"cik":"0001831218","reported_name":"Bohen Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-29T23:56:53.000Z","date":"2021-09-27","kind":"exercise","acquired":false,"shares":1085,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"(A) 256,992 of the shares subject to the option vest on September 1, 2021, (B) 2,411 of the shares subject to the option vest on January 1, 2022 and 2,410 of the shares subject to the option vest on January 1 of each of 2023 and 2024 and (C) 23,143 of the shares subject to the option vest on the 1st day of each month (other than on September 1, 2021 and each of January 1, 2022, 2023 and 2024) following September 1, 2021, plus an additional 23 shares on September 1, 2024. Subject to, in each case of (A) - (C) above, the Reporting Person's continuous service on each applicable vesting date. The stock option is early exercisable."}],"balance_after":971316,"derivative":{"exercise_price":4.824,"expiration_date":"2030-11-18","underlying":"Common Stock","underlying_shares":1085},"source":{"system":"sec-edgar","filing":"0001415889-21-004613","document":"form4-09292021_040935.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1750284/000141588921004613/form4-09292021_040935.xml","form_type":"4"}},{"id":2556347,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":67695,"kind":"person","name":"Bohen Sean","position":1,"cik":"0001831218","reported_name":"Bohen Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2021-09-29T23:56:53.000Z","date":"2021-09-27","kind":"sale","acquired":false,"shares":1085,"price":30.07,"value":32625.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."}],"balance_after":52514,"source":{"system":"sec-edgar","filing":"0001415889-21-004613","document":"form4-09292021_040935.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1750284/000141588921004613/form4-09292021_040935.xml","form_type":"4"}},{"id":2556346,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":67695,"kind":"person","name":"Bohen Sean","position":1,"cik":"0001831218","reported_name":"Bohen Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2021-09-29T23:56:53.000Z","date":"2021-09-27","kind":"exercise","acquired":true,"shares":1085,"price":4.824,"value":5234.04,"ownership":{"direct":true},"balance_after":53599,"source":{"system":"sec-edgar","filing":"0001415889-21-004613","document":"form4-09292021_040935.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1750284/000141588921004613/form4-09292021_040935.xml","form_type":"4"}},{"id":2574314,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":67695,"kind":"person","name":"Bohen Sean","position":1,"cik":"0001831218","reported_name":"Bohen Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-09T20:25:20.000Z","date":"2021-09-08","kind":"exercise","acquired":false,"shares":2631,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"(A) 256,992 of the shares subject to the option vest on September 1, 2021, (B) 2,411 of the shares subject to the option vest on January 1, 2022 and 2,410 of the shares subject to the option vest on January 1 of each of 2023 and 2024 and (C) 23,143 of the shares subject to the option vest on the 1st day of each month (other than on September 1, 2021 and each of January 1, 2022, 2023 and 2024) following September 1, 2021, plus an additional 23 shares on September 1, 2024. Subject to, in each case of (A) - (C) above, the Reporting Person's continuous service on each applicable vesting date. The stock option is early exercisable."}],"balance_after":972401,"derivative":{"exercise_price":4.824,"expiration_date":"2030-11-18","underlying":"Common Stock","underlying_shares":2631},"source":{"system":"sec-edgar","filing":"0001415889-21-004306","document":"form4-09092021_010907.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1750284/000141588921004306/form4-09092021_010907.xml","form_type":"4"}},{"id":2574313,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":67695,"kind":"person","name":"Bohen Sean","position":1,"cik":"0001831218","reported_name":"Bohen Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-09T20:25:20.000Z","date":"2021-09-07","kind":"exercise","acquired":false,"shares":413,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"(A) 256,992 of the shares subject to the option vest on September 1, 2021, (B) 2,411 of the shares subject to the option vest on January 1, 2022 and 2,410 of the shares subject to the option vest on January 1 of each of 2023 and 2024 and (C) 23,143 of the shares subject to the option vest on the 1st day of each month (other than on September 1, 2021 and each of January 1, 2022, 2023 and 2024) following September 1, 2021, plus an additional 23 shares on September 1, 2024. Subject to, in each case of (A) - (C) above, the Reporting Person's continuous service on each applicable vesting date. The stock option is early exercisable."}],"balance_after":975032,"derivative":{"exercise_price":4.824,"expiration_date":"2030-11-18","underlying":"Common Stock","underlying_shares":413},"source":{"system":"sec-edgar","filing":"0001415889-21-004306","document":"form4-09092021_010907.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1750284/000141588921004306/form4-09092021_010907.xml","form_type":"4"}},{"id":2574312,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":67695,"kind":"person","name":"Bohen Sean","position":1,"cik":"0001831218","reported_name":"Bohen Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2021-09-09T20:25:20.000Z","date":"2021-09-08","kind":"sale","acquired":false,"shares":2631,"price":30,"value":78930.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."}],"balance_after":52514,"source":{"system":"sec-edgar","filing":"0001415889-21-004306","document":"form4-09092021_010907.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1750284/000141588921004306/form4-09092021_010907.xml","form_type":"4"}},{"id":2574311,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":67695,"kind":"person","name":"Bohen Sean","position":1,"cik":"0001831218","reported_name":"Bohen Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2021-09-09T20:25:20.000Z","date":"2021-09-08","kind":"exercise","acquired":true,"shares":2631,"price":4.824,"value":12691.944,"ownership":{"direct":true},"balance_after":56905,"source":{"system":"sec-edgar","filing":"0001415889-21-004306","document":"form4-09092021_010907.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1750284/000141588921004306/form4-09092021_010907.xml","form_type":"4"}},{"id":2574310,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":67695,"kind":"person","name":"Bohen Sean","position":1,"cik":"0001831218","reported_name":"Bohen Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2021-09-09T20:25:20.000Z","date":"2021-09-07","kind":"sale","acquired":false,"shares":413,"price":30.08,"value":12423.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $30.08, and the range of prices were between $30.00 and $30.12. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":54274,"source":{"system":"sec-edgar","filing":"0001415889-21-004306","document":"form4-09092021_010907.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1750284/000141588921004306/form4-09092021_010907.xml","form_type":"4"}},{"id":2574309,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":67695,"kind":"person","name":"Bohen Sean","position":1,"cik":"0001831218","reported_name":"Bohen Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2021-09-09T20:25:20.000Z","date":"2021-09-07","kind":"exercise","acquired":true,"shares":413,"price":4.824,"value":1992.312,"ownership":{"direct":true},"balance_after":54687,"source":{"system":"sec-edgar","filing":"0001415889-21-004306","document":"form4-09092021_010907.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1750284/000141588921004306/form4-09092021_010907.xml","form_type":"4"}},{"id":2578298,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":67695,"kind":"person","name":"Bohen Sean","position":1,"cik":"0001831218","reported_name":"Bohen Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-03T21:16:22.000Z","date":"2021-09-01","kind":"exercise","acquired":false,"shares":871,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"(A) 256,992 of the shares subject to the option vest on September 1, 2021, (B) 2,411 of the shares subject to the option vest on January 1, 2022 and 2,410 of the shares subject to the option vest on January 1 of each of 2023 and 2024 and (C) 23,143 of the shares subject to the option vest on the 1st day of each month (other than on September 1, 2021 and each of January 1, 2022, 2023 and 2024) following September 1, 2021, plus an additional 23 shares on September 1, 2024. Subject to, in each case of (A) - (C) above, the Reporting Person's continuous service on each applicable vesting date. The stock option is early exercisable."}],"balance_after":975445,"derivative":{"exercise_price":4.824,"expiration_date":"2030-11-18","underlying":"Common Stock","underlying_shares":871},"source":{"system":"sec-edgar","filing":"0001415889-21-004247","document":"form4-09032021_020903.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1750284/000141588921004247/form4-09032021_020903.xml","form_type":"4"}},{"id":2578297,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":67695,"kind":"person","name":"Bohen Sean","position":1,"cik":"0001831218","reported_name":"Bohen Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2021-09-03T21:16:22.000Z","date":"2021-09-01","kind":"sale","acquired":false,"shares":871,"price":30.05,"value":26173.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The weighted average sale price for the transaction reported was $30.05, and the range of prices were between $30.01 and $30.15. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":54274,"source":{"system":"sec-edgar","filing":"0001415889-21-004247","document":"form4-09032021_020903.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1750284/000141588921004247/form4-09032021_020903.xml","form_type":"4"}},{"id":2578296,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":67695,"kind":"person","name":"Bohen Sean","position":1,"cik":"0001831218","reported_name":"Bohen Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2021-09-03T21:16:22.000Z","date":"2021-09-01","kind":"exercise","acquired":true,"shares":871,"price":4.824,"value":4201.704,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 2,625 shares acquired under the issuer's Employee Stock Purchase Plan on May 14, 2021."}],"balance_after":55145,"source":{"system":"sec-edgar","filing":"0001415889-21-004247","document":"form4-09032021_020903.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1750284/000141588921004247/form4-09032021_020903.xml","form_type":"4"}},{"id":2785244,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":67695,"kind":"person","name":"Bohen Sean","position":1,"cik":"0001831218","reported_name":"Bohen Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-16T23:05:59.000Z","date":"2021-03-15","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vest on March 15, 2022 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date."}],"balance_after":75000,"derivative":{"exercise_price":45.63,"expiration_date":"2031-03-14","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001209191-21-021109","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1750284/000120919121021109/doc4.xml","form_type":"4"}},{"id":2972596,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":67695,"kind":"person","name":"Bohen Sean","position":1,"cik":"0001831218","reported_name":"Bohen Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-19T23:41:39.000Z","date":"2020-11-18","kind":"grant","acquired":true,"shares":538020,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the option vest on November 18, 2021 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date."}],"balance_after":538020,"derivative":{"exercise_price":19,"expiration_date":"2030-11-17","underlying":"Common Stock","underlying_shares":538020},"source":{"system":"sec-edgar","filing":"0001209191-20-059509","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1750284/000120919120059509/doc4.xml","form_type":"4"}},{"id":2972595,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":67695,"kind":"person","name":"Bohen Sean","position":1,"cik":"0001831218","reported_name":"Bohen Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-19T23:41:39.000Z","date":"2020-09-23","kind":"exercise","acquired":false,"shares":51649,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"(A) 256,992 of the shares subject to the option vest on September 1, 2021, (B) 2,411 of the shares subject to the option vest on January 1, 2022 and 2,410 of the shares subject to the option vest on January 1 of each of 2023 and 2024 and (C) 23,143 of the shares subject to the option vest on the 1st day of each month (other than on September 1, 2021 and each of January 1, 2022, 2023 and 2024) following September 1, 2021, plus an additional 23 shares on September 1, 2024. Subject to, in each case of (A) - (C) above, the Reporting Person's continuous service on each applicable vesting date. The stock option is early exercisable."}],"balance_after":976316,"derivative":{"exercise_price":4.824,"expiration_date":"2030-09-18","underlying":"Common Stock","underlying_shares":51649},"source":{"system":"sec-edgar","filing":"0001209191-20-059509","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1750284/000120919120059509/doc4.xml","form_type":"4"}},{"id":2972594,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":67695,"kind":"person","name":"Bohen Sean","position":1,"cik":"0001831218","reported_name":"Bohen Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-19T23:41:39.000Z","date":"2020-09-19","kind":"grant","acquired":true,"shares":1027965,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"(A) 256,992 of the shares subject to the option vest on September 1, 2021, (B) 2,411 of the shares subject to the option vest on January 1, 2022 and 2,410 of the shares subject to the option vest on January 1 of each of 2023 and 2024 and (C) 23,143 of the shares subject to the option vest on the 1st day of each month (other than on September 1, 2021 and each of January 1, 2022, 2023 and 2024) following September 1, 2021, plus an additional 23 shares on September 1, 2024. Subject to, in each case of (A) - (C) above, the Reporting Person's continuous service on each applicable vesting date. The stock option is early exercisable."}],"balance_after":1027965,"derivative":{"exercise_price":4.824,"expiration_date":"2030-09-18","underlying":"Common Stock","underlying_shares":1027965},"source":{"system":"sec-edgar","filing":"0001209191-20-059509","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1750284/000120919120059509/doc4.xml","form_type":"4"}},{"id":2972593,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":67695,"kind":"person","name":"Bohen Sean","position":1,"cik":"0001831218","reported_name":"Bohen Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-19T23:41:39.000Z","date":"2020-09-19","kind":"grant","acquired":true,"shares":82931,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"20,732 of the shares subject to the option vest on September 1, 2021 and 20,733 of the shares subject to the option vest on January 1 of each of\n2022, 2023 and 2024, subject to the Reporting Person's continuous service on each applicable vesting date."}],"balance_after":82931,"derivative":{"exercise_price":4.824,"expiration_date":"2030-09-18","underlying":"Common Stock","underlying_shares":82931},"source":{"system":"sec-edgar","filing":"0001209191-20-059509","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1750284/000120919120059509/doc4.xml","form_type":"4"}},{"id":2972592,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":67695,"kind":"person","name":"Bohen Sean","position":1,"cik":"0001831218","reported_name":"Bohen Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-11-19T23:41:39.000Z","date":"2020-09-23","kind":"exercise","acquired":true,"shares":51649,"price":4.824,"value":249154.776,"ownership":{"direct":true},"balance_after":51649,"source":{"system":"sec-edgar","filing":"0001209191-20-059509","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1750284/000120919120059509/doc4.xml","form_type":"4"}}]}